Sharkey RM - Search Results

1

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report.

Han C, Bellone S, Schwartz PE, Govindan SV, Sharkey RM, Goldenberg DM, Santin AD. Han C, et al. Among authors: sharkey rm. Gynecol Oncol Rep. 2018 May 23;25:37-40. doi: 10.1016/j.gore.2018.05.009. eCollection 2018 Aug. Gynecol Oncol Rep. 2018. PMID: 29977989 Free PMC article.

2

Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas.

Blumenthal RD, Sharkey RM, Kashi R, Natale AM, Goldenberg DM. Blumenthal RD, et al. Among authors: sharkey rm. Int J Cancer. 1992 Jul 30;51(6):935-41. doi: 10.1002/ijc.2910510617. Int J Cancer. 1992. PMID: 1322378

3

Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor.

Boerman OC, Sharkey RM, Wong GY, Blumenthal RD, Aninipot RL, Goldenberg DM. Boerman OC, et al. Among authors: sharkey rm. Cancer Immunol Immunother. 1992;35(2):127-34. doi: 10.1007/BF01741860. Cancer Immunol Immunother. 1992. PMID: 1375872 Free PMC article.

4

Haematological effects of radioimmunotherapy in cancer patients.

Stein R, Sharkey RM, Goldenberg DM. Stein R, et al. Among authors: sharkey rm. Br J Haematol. 1992 Jan;80(1):69-76. doi: 10.1111/j.1365-2141.1992.tb06402.x. Br J Haematol. 1992. PMID: 1536812

5

Dose escalation of radioantibody in a mouse model with the use of recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor intervention to reduce myelosuppression.

Blumenthal RD, Sharkey RM, Goldenberg DM. Blumenthal RD, et al. Among authors: sharkey rm. J Natl Cancer Inst. 1992 Mar 18;84(6):399-407. doi: 10.1093/jnci/84.6.399. J Natl Cancer Inst. 1992. PMID: 1538418

6

Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice.

Sharkey RM, Boerman OC, Natale A, Pawlyk D, Monestier M, Losman MJ, Goldenberg DM. Sharkey RM, et al. Int J Cancer. 1992 May 8;51(2):266-73. doi: 10.1002/ijc.2910510216. Int J Cancer. 1992. PMID: 1568794

7

The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors.

Boerman OC, Sharkey RM, Blumenthal RD, Aninipot RL, Goldenberg DM. Boerman OC, et al. Among authors: sharkey rm. Int J Cancer. 1992 May 28;51(3):470-5. doi: 10.1002/ijc.2910510322. Int J Cancer. 1992. PMID: 1592537

8

Labeling of monoclonal antibody conjugates with 90Y.

Motta-Hennessy C, Sharkey RM, Goldenberg DM. Motta-Hennessy C, et al. Among authors: sharkey rm. Int J Rad Appl Instrum A. 1991;42(5):421-6. doi: 10.1016/0883-2889(91)90099-m. Int J Rad Appl Instrum A. 1991. PMID: 1646187

9

A new murine monoclonal antibody against human hepatoma.

Stein R, Wang ZF, Sharkey RM, Klein KM, Goldenberg DM. Stein R, et al. Among authors: sharkey rm. Hybridoma. 1991 Apr;10(2):255-67. doi: 10.1089/hyb.1991.10.255. Hybridoma. 1991. PMID: 1651901

10

The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study.

Blumenthal RD, Fand I, Sharkey RM, Boerman OC, Kashi R, Goldenberg DM. Blumenthal RD, et al. Among authors: sharkey rm. Cancer Immunol Immunother. 1991;33(6):351-8. doi: 10.1007/BF01741594. Cancer Immunol Immunother. 1991. PMID: 1652355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters